JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JB Accepts, published online ahead of print on 20 April 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JB.01889-06v1
189/13/4739    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neff, L.
Right arrow Articles by Bas, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neff, L.
Right arrow Articles by Bas, S.

 Previous Article  |  Next Article 

J. Bacteriol. doi:10.1128/JB.01889-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein

Laurence Neff, Sawsan Daher, Patrick Muzzin, Ursula Spenato, Fazil Gülaçar, Cem Gabay, and Sylvette Bas*

Division of Rheumatology, Department of Internal Medicine, Geneva University Hospital, Department of Pathology and Immunology, Geneva Medical School, Laboratory of Mass Spectrometry, University of Geneva, and Department of Cell Physiology and Metabolism, Geneva Medical School, Switzerland

* To whom correspondence should be addressed. Email: sylvette.bas{at}hcuge.ch.


   Abstract

Macrophage infectivity potentiator (MIP) was originally reported to be a chlamydial lipoprotein from experiments showing incorporation of radiolabeled palmitic acid into the native and recombinant MIP, inhibition of post-translational processing of recombinant MIP by globomycin, known to inhibit signal peptidase II, and solubility of native MIP in Triton X-114. However, the detailed structural characterization of the lipidic moiety on MIP has never been fully elucidated. In this study, bioinformatics and mass spectrometry analysis, as well as radiolabeling and immunochemical experiments were conducted to further characterize MIP structure and subcellular localization. In silico analysis showed that the amino acid sequence of MIP is conserved across Chlamydiae species. A potential signal sequence with a contained lipobox was identified and a recombinant variant C20A was prepared by substituting the probable lipobox cysteine for an alanine. Both incorporation of [U-14C]-esterified glycerol and [U-14C]-palmitic acid as well as post-translational processing that was inhibitable by globomycin, were observed in wild type recombinant MIP, but not in the C20A recombinant MIP variant. Fatty acid content of native and recombinant MIP were analyzed by gas chromatography-mass spectrometry and the presence of amide-linked fatty acids was investigated by alkaline methanolysis in recombinant MIP. These results demonstrated a lipid modification in MIP similar to that of other procaryotic lipoproteins. In addition, MIP was detected in outer membrane preparation of Chlamydia trachomatis elementary bodies, and was shown to be present at the surface of elementary bodies by surface biotinylation and surface immunoprecipitation experiments.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.